Cargando…
Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
Hepatocellular cancer is the sixth most frequently diagnosed malignant disease worldwide, and was responsible for tens of millions of deaths in 2020; however, treatment options for patients with advanced hepatocellular carcinoma remain limited. Immunotherapy has undergone rapid development over rece...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450565/ https://www.ncbi.nlm.nih.gov/pubmed/34552872 http://dx.doi.org/10.3389/fonc.2021.716844 |